全球週边介入市场

2030年，全球週边介入市场规模将达到163亿美元

全球外周介入市场规模预计在2024年达到108亿美元，预计2024年至2030年期间的复合年增长率为7.1%，到2030年将达到163亿美元。动脉粥状硬化斑块切除术切除术是本报告分析的细分市场之一，预计其复合年增长率为5.7%，到分析期结束时规模将达到65亿美元。支架置入术细分市场在分析期间的复合年增长率预计为7.4%。

美国市场规模估计为 29 亿美元，中国市场预期复合年增长率为 10.9%

美国外周介入市场规模预计在2024年达到29亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到34亿美元，在2024-2030年的分析期间内，复合年增长率为10.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.7%和6.8%。在欧洲，预计德国市场的复合年增长率为4.7%。

全球週边介入市场－主要趋势与驱动因素摘要

为什么週边介入在现代血管治疗中越来越受到关注？

随着慢性血管疾病在世界各地日益普遍，週边介入治疗（即治疗心臟和脑外血管阻塞和异常的微创手术）正成为血管治疗的重要组成部分。这些手术包括血管成形术、置入术动脉粥状硬化斑块切除术、斑块切除术、血栓切除术、栓塞术和静脉内消融术。它们用于治疗周边动脉疾病(PAD)、深层静脉栓塞症(DVT)、静脉曲张、动脉瘤和动静脉畸形。

受老化、糖尿病、吸烟和久坐不动等因素的影响，週边动脉疾病 (PAD) 病例迅速增加，这推动了对导管血运重组手术的需求，这种手术可避免开放式血管手术相关的併发症和恢復时间。血管内手术利用低位器械，透过股动脉、桡动脉或足底入路引导，扩张血管、清除斑块、血栓。随着对早期血管损伤认识的提高，越来越多的患者在出现危急性肢体缺血(CLI) 和组织缺损之前，接受积极的周边介入治疗。

非动脉粥状硬化性血管疾病，例如静脉逆流、骨盆腔淤血症候群和透析通路功能障碍，也越来越多地透过週边手术进行治疗。混合血管手术室、门诊实验室 (OBL) 和介入放射科的兴起，使得手术可及性和当日出院途径更加便捷。朝向以价值为基础的血管护理模式的转变，强化了微创、经济高效且能优化疗效的介入性手术的重要性。

设备创新和成像技术如何重新定义结果？

器械小型化、导管导引线技术的改进以及导管可操作性的提升彻底改变了周边介入治疗。药物涂层球囊 (DCB) 和药物释放型支架 (DES) 降低了股腘动脉和腘下动脉区域的血管再阻塞率。动脉粥状硬化斑块切除器械——旋转式、轨道式、雷射式和定向式——可根据特定的病变形态和钙化模式进行定制，从而改善了复杂外周动脉疾病 (PAD) 中的斑块减灭和血管准备。

目前，超音波和血管内显像模式（例如血管内超音波(IVUS) 和光同调断层扫瞄(OCT)）正被用于即时表征病变、指导器械尺寸调整和评估术后结果。 3D 血管导航和机器人导管也正在接受测试，以提高手术控制和可重复性。栓塞保护装置和血管闭合系统正在提高高风险手术的安全裕度。

在静脉介入治疗中，雷射和射频消融术导管正在取代手术剥离术来治疗静脉曲张，从而加快患者康復并减少復发。在深部静脉肺动脉栓塞中，机械血栓切除系统（例如抽吸导管和旋转篮）无需使用全身溶栓药物即可清除血栓，从而降低出血风险。支架材料、生物分解性支架和鞘套系统的创新也正在扩大週边治疗的解剖范围和耐久性。

哪些临床领域和区域市场正在引领週边干预的成长？

週边介入涵盖众多专业领域，包括介入性心臟病学、介入性放射学、血管外科和肾臟病学。临床发展最快的领域是周边动脉疾病 (PAD) 的管理，尤其是针对糖尿病和肾臟病患者的膝下 (BTK) 介入治疗。随着专用交叉装置和低切迹球囊的出现，长钙化病变的血管重组和慢性完全阻塞 (CTO) 的治疗正变得越来越可行。

透析通路领域也是一个不断成长的利基市场，透过球囊血管成形术、血管支架植入和血栓切​​除术治疗动静脉瘘 (AVF) 狭窄，以恢復血流并延长通路。随着新型栓塞线圈、黏合剂和硬化剂的出现，静脉注射介入治疗静脉逆流、骨盆腔静脉功能不全和血栓后症候群也不断扩展。子宫肌瘤栓塞和摄护腺动脉栓塞是生殖健康领域非肿瘤性、微创的外科手术治疗方法。

从地理上看，北美凭藉其高手术量、强大的介入基础设施和广泛的报销范围占据主导地位。欧洲专注于个人化血管治疗途径以及DCB和动脉粥状硬化斑块切除术系统的采用。亚太地区，尤其是中国和印度，正经历爆炸性成长，这得益于血管疾病负担的增加、导管室渗透率的提高以及介入培训的不断扩大。中东和拉丁美洲市场正透过公共和私人医疗保健投资逐步采用周边介入治疗。

推动全球週边介入市场成长的因素有哪些？

全球週边介入市场的成长是由周边血管疾病盛行率的上升、技术的快速创新、微创治疗的日益普及以及全球向门诊病人和预防性血管护理的转变所驱动。随着慢性血管疾病负担的增加，特别是在老年人口和糖尿病患者中，週边介入提供了一种有效且高效的治疗模式。

新一代DCB、支架平台和栓塞剂的监管核准正在加速该手术的普及，而保险报销政策的出台、门诊中心血管内治疗的整合以及跨专科培训的加强，则正在扩大该手术的适用范围和接受度。患者对非手术介入的偏好，加上其改善的长期疗效和更低的併发症风险，进一步推动了市场的发展动能。

随着血管护理发展成为数据主导、结果为中心的专业，週边干预仍将是护理的基石，并且随着医疗保健系统优先考虑肢体保护、降低心血管风险和微创疾病管理策略，市场有望继续扩张。

部分

介入类型（动脉粥状硬化斑块切除术硬化斑块切除术、支架置入术、血管成形术、血栓切除术、栓塞术）、器械类型（介入性导管、介入支架、导管导引线、介入性球囊、栓塞线圈）、适应症（冠状动脉疾病适应症、中风适应症、週边动脉周边动脉疾病适应症、肾动脉狭窄适应症、终端使用者手术、最终使用者研究诊所使用者、诊所使用者研究中心

受访公司范例

• Abbott Laboratories（Abbott Vascular）
• Bayer AG
• Biotronik SE & Co KG
• Boston Scientific Corp.
• Cardinal Health
• Cook Medical
• Cordis（Johnson & Johnson）
• Edward Lifesciences
• Getinge AB
• Inari Medical
• Johnson & Johnson（Cordis, Biosense）
• LeMaitre Vascular
• Medtronic plc
• Merit Medical Systems
• NuVasive（spine but vascular tools）
• Penumbra Inc.
• Philips（Royal Philips）
• Reflow Medical
• Siemens Healthineers
• Stryker（Inari acquisition）

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Peripheral Interventions Market to Reach US$16.3 Billion by 2030

The global market for Peripheral Interventions estimated at US$10.8 Billion in the year 2024, is expected to reach US$16.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Atherectomy Intervention, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$6.5 Billion by the end of the analysis period. Growth in the Stent Implantation Intervention segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 10.9% CAGR

The Peripheral Interventions market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Peripheral Interventions Market - Key Trends & Drivers Summarized

Why Are Peripheral Interventions Gaining Traction in Modern Vascular Therapy?

Peripheral interventions-minimally invasive procedures that treat blockages or abnormalities in blood vessels outside the heart and brain-are becoming an integral part of vascular care as chronic vascular diseases escalate globally. These interventions encompass procedures such as angioplasty, stenting, atherectomy, thrombectomy, embolization, and endovenous ablation. They are employed to manage peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, aneurysms, and arteriovenous malformations.

The surge in PAD cases, attributed to aging populations, diabetes, smoking, and sedentary lifestyles, is fueling demand for catheter-based revascularization techniques that avoid the complications and recovery times associated with open vascular surgery. Endovascular therapy allows for vessel dilation, plaque removal, or clot extraction using low-profile devices guided via femoral, radial, or pedal access. As awareness about early-stage vascular disease improves, more patients are being treated proactively using peripheral intervention before the onset of critical limb ischemia (CLI) or tissue loss.

Non-atherosclerotic vascular conditions such as venous reflux disease, pelvic congestion syndrome, and dialysis access dysfunction are also being increasingly managed using peripheral techniques. The growth of hybrid vascular ORs, outpatient-based labs (OBLs), and interventional radiology suites is enabling greater procedural access and same-day discharge pathways. The shift toward value-based vascular care models is reinforcing the importance of less invasive, cost-effective, and outcome-optimized interventional therapies.

How Are Device Innovations and Imaging Technologies Redefining Outcomes?

Device miniaturization, improved guidewire technology, and enhanced catheter maneuverability have revolutionized peripheral interventions. Drug-coated balloons (DCBs) and drug-eluting stents (DES) have reduced restenosis rates in femoropopliteal and infrapopliteal segments. Atherectomy devices-rotational, orbital, laser, or directional-are being tailored to specific lesion morphologies and calcification patterns, improving plaque debulking and vessel preparation in complex PAD.

Ultrasound and intravascular imaging modalities such as IVUS (intravascular ultrasound) and OCT (optical coherence tomography) are now being deployed to assess lesion characteristics, guide device sizing, and evaluate post-procedural outcomes in real-time. 3D vascular navigation and robotic catheters are also being tested for enhanced procedural control and reproducibility. Embolic protection devices and vessel closure systems are increasing safety margins in high-risk procedures.

In venous interventions, laser and radiofrequency ablation catheters are replacing surgical stripping for varicose vein treatment, providing faster recovery and reduced recurrence. For DVT and pulmonary embolism, mechanical thrombectomy systems like aspiration catheters and rotating baskets are allowing for clot removal without systemic thrombolytics, reducing bleeding risks. Innovations in scaffold materials, biodegradable stents, and sheathless systems are also expanding the anatomical reach and durability of peripheral therapies.

Which Clinical Segments and Regional Markets Are Leading Peripheral Interventional Growth?

Peripheral interventions span a wide range of specialties including interventional cardiology, interventional radiology, vascular surgery, and nephrology. The most significant clinical growth is occurring in PAD management, especially in below-the-knee (BTK) interventions for patients with diabetes or renal disease. Revascularization of long, calcified lesions and treatment of chronic total occlusions (CTOs) are becoming more feasible with specialty crossing devices and low-profile balloons.

The dialysis access segment is another growing niche, where arteriovenous fistula (AVF) stenoses are treated using balloon angioplasty, stent grafts, or thrombectomy to restore flow and preserve access longevity. Endovenous interventions for venous reflux, pelvic venous insufficiency, and post-thrombotic syndrome are also expanding with new embolization coils, adhesives, and sclerosants. Uterine fibroid embolization and prostate artery embolization represent non-oncologic, minimally invasive alternatives to surgery in the reproductive health domain.

Geographically, North America dominates due to high procedural volumes, robust interventional infrastructure, and wide reimbursement coverage. Europe is focused on personalized vascular care pathways and adoption of DCBs and atherectomy systems. Asia-Pacific, particularly China and India, is seeing explosive growth due to rising vascular disease burden, increasing cath lab penetration, and expanding interventional training. Middle Eastern and Latin American markets are gradually adopting peripheral interventions through public-private healthcare investments.

What Is Driving Growth in the Global Peripheral Interventions Market?

The growth in the global peripheral interventions market is driven by the rising prevalence of peripheral vascular disease, rapid technology innovation, increasing adoption of minimally invasive therapies, and the global shift toward outpatient and preventive vascular care. As the burden of chronic vascular conditions rises, particularly in aging and diabetic populations, peripheral interventions offer an effective and efficient treatment paradigm.

Regulatory approvals for newer-generation DCBs, stent platforms, and embolic agents are accelerating procedural adoption. Meanwhile, supportive reimbursement policies, integration of endovascular procedures in outpatient centers, and enhanced cross-specialty training are expanding procedural reach and acceptance. Patient preference for non-surgical interventions, combined with improved long-term outcomes and lower complication risks, further strengthens market momentum.

As vascular care evolves into a data-driven, outcome-focused specialty, peripheral interventions will remain a cornerstone of therapy. The market is poised for continued expansion as healthcare systems prioritize limb preservation, cardiovascular risk reduction, and minimally invasive disease management strategies.

SCOPE OF STUDY:

The report analyzes the Peripheral Interventions market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Intervention Type (Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention, Embolization Intervention); Device Type (Interventional Catheters, Interventional Stents, Guide Wires, Interventional Balloons, Embolic Coils); Indication (Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication, Carotid Artery Stenosis Indication); End-User (Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User, Research Institutes End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories (Abbott Vascular)
• Bayer AG
• Biotronik SE & Co KG
• Boston Scientific Corp.
• Cardinal Health
• Cook Medical
• Cordis (Johnson & Johnson)
• Edward Lifesciences
• Getinge AB
• Inari Medical
• Johnson & Johnson (Cordis, Biosense)
• LeMaitre Vascular
• Medtronic plc
• Merit Medical Systems
• NuVasive (spine but vascular tools)
• Penumbra Inc.
• Philips (Royal Philips)
• Reflow Medical
• Siemens Healthineers
• Stryker (Inari acquisition)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Peripheral Interventions - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Peripheral Artery Disease Throws the Spotlight on Minimally Invasive Interventions
  • Expansion of Aging Population Base Accelerates Demand for Endovascular Treatment Options
  • Technological Advancements in Drug-Eluting Balloons and Stents Drive Product Innovation
  • Growing Adoption of Atherectomy and Thrombectomy Devices Spurs Market Expansion
  • Shift Toward Ambulatory Surgical Centers Strengthens Business Case for Outpatient Peripheral Procedures
  • Integration of Imaging-Guided Navigation Systems Enhances Precision in Peripheral Interventions
  • Rising Incidence of Diabetes and Obesity Drives Need for Lower Limb Revascularization Procedures
  • Expansion of Healthcare Infrastructure in Emerging Markets Propels Access to Peripheral Treatments
  • Increased Reimbursement Support in Developed Markets Boosts Adoption of Endovascular Devices
  • Development of Bioabsorbable and Next-Gen Scaffold Technologies Spurs Device Innovation
  • Vascular Surgeons and Interventional Radiologists Drive Procedural Volume Through Cross-Specialty Growth
  • Patient Preference for Non-Surgical Therapies Expands Addressable Market for Peripheral Interventions
  • Favorable Clinical Trial Outcomes Strengthen Physician Confidence in Device-Based Interventions
  • Growing Focus on Limb Salvage Strategies in Critical Limb Ischemia Supports Market Penetration
  • Integration of Artificial Intelligence in Procedural Planning Enhances Treatment Outcomes
  • Rising Burden of Smoking-Linked Atherosclerotic Disease Fuels Demand for Vascular Access Tools
  • Hospital Consolidation Trends Drive Standardization of Peripheral Vascular Device Procurement
  • Emergence of Robotic and Telerobotic Intervention Systems Expands Technological Frontiers
  • Global Increase in Endovascular Fellowships Supports Skilled Workforce Development
  • Regulatory Fast-Track Approvals for Life-Saving Devices Sustain Innovation in Peripheral Intervention Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Peripheral Interventions Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Peripheral Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Atherectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Atherectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Atherectomy Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Stent Implantation Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Stent Implantation Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Stent Implantation Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Angioplasty Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Angioplasty Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Angioplasty Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Thrombectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Thrombectomy Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Thrombectomy Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Embolization Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Embolization Intervention by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Embolization Intervention by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Embolic Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Interventional Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Interventional Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Interventional Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Interventional Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Interventional Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Interventional Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Guide Wires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Guide Wires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Guide Wires by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Interventional Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Interventional Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Interventional Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Coronary Artery Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Coronary Artery Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Coronary Artery Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Stroke Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Peripheral Arterial Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Peripheral Arterial Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Renal Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Renal Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Renal Artery Stenosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Carotid Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Carotid Artery Stenosis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Carotid Artery Stenosis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: World 16-Year Perspective for Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: World 16-Year Perspective for Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: USA 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: USA 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: USA 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: USA 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Canada 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Canada 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Canada 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Canada 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• JAPAN
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Japan 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Japan 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Japan 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Japan 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• CHINA
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: China 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: China 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: China 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: China 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• EUROPE
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Peripheral Interventions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Europe 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Europe 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Europe 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• FRANCE
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 125: France Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: France 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: France 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: France 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: France 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• GERMANY
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Germany 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Germany 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Germany 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Germany 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Italy 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Italy 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Italy 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Italy 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 161: UK Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: UK 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: UK 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: UK 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: UK 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Spain 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Spain 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Spain 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Spain 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Russia 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Russia 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Russia 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Russia 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Peripheral Interventions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Australia 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Australia 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Australia 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Australia 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• INDIA
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 236: India Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: India 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: India 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: India 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: India 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: South Korea 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: South Korea 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: South Korea 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: South Korea 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Peripheral Interventions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Latin America 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Latin America 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Latin America 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Argentina 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Argentina 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Argentina 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Argentina 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Brazil 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Brazil 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Brazil 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Brazil 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Mexico 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Mexico 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Mexico 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Mexico 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Peripheral Interventions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Peripheral Interventions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Middle East 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Middle East 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Middle East 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Iran 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Iran 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Iran 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Iran 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Israel 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Israel 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Israel 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Israel 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: UAE 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: UAE 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: UAE 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: UAE 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030
• AFRICA
  • Peripheral Interventions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Peripheral Interventions by Intervention Type - Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 412: Africa 16-Year Perspective for Peripheral Interventions by Intervention Type - Percentage Breakdown of Value Sales for Atherectomy Intervention, Stent Implantation Intervention, Angioplasty Intervention, Thrombectomy Intervention and Embolization Intervention for the Years 2014, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Peripheral Interventions by Device Type - Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 415: Africa 16-Year Perspective for Peripheral Interventions by Device Type - Percentage Breakdown of Value Sales for Embolic Coils, Interventional Catheters, Interventional Stents, Guide Wires and Interventional Balloons for the Years 2014, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Peripheral Interventions by Indication - Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 418: Africa 16-Year Perspective for Peripheral Interventions by Indication - Percentage Breakdown of Value Sales for Coronary Artery Disease Indication, Stroke Indication, Peripheral Arterial Disease Indication, Renal Artery Stenosis Indication and Carotid Artery Stenosis Indication for the Years 2014, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Peripheral Interventions by End-user - Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 421: Africa 16-Year Perspective for Peripheral Interventions by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Ambulatory Surgery Centers End-User, Clinics End-User and Research Institutes End-User for the Years 2014, 2025 & 2030

IV. COMPETITION